Axsome Therapeutics Inc.
AXSM | NASDAQ
$132.57
-$11.86 (-8.21%)
Nov 2, 2026, 2:32 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 218.38M | 191.2M | 196M | 170.99M | 150.04M | 121.46M | 118.77M | 104.76M | 87.17M | 75M | 71.53M | 57.79M | 46.7M | 94.58M | 24.37M | 16.85M | 8.82M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 13.56M | 14.73M | 12.33M | 11.91M | 13.45M | 9.79M | 10.51M | 8.44M | 8.06M | 6.3M | 7.38M | 6.53M | 4.6M | 7.56M | 2.29M | 1.92M | 983K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 204.81M | 176.48M | 183.67M | 159.08M | 136.59M | 111.67M | 108.25M | 96.33M | 79.11M | 68.7M | 64.15M | 51.26M | 42.1M | 87.02M | 22.08M | 14.92M | 7.84M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -49.65M | -63.36M | -29.43M | -46.11M | -36.71M | -56.98M | -72.62M | -62.62M | -78.05M | -67.28M | -98.27M | -62.12M | -65.06M | -6.37M | -59.92M | -42.41M | -39.18M | -38.29M | -32.61M | -33.41M | -30.85M | -27.84M |
Interest Income | n/a | n/a | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -51.19M | -64.54M | -28.13M | -47.23M | -48.93M | -59.41M | -74.83M | -64.6M | -79.35M | -68.36M | -98.98M | -62.88M | -67.79M | -8.64M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M | -29.26M |
Net Income | -51.31M | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.35M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M | -29.26M |
Selling & General & Admin | 208.14M | 185M | 169.3M | 150.24M | 130.28M | 120.79M | 113.27M | 95.56M | 103.55M | 98.97M | 86.81M | 83.19M | 78.94M | 74.19M | 61.5M | 40.89M | 31.16M | 25.7M | 18.83M | 20.23M | 16.34M | 11.25M |
Research & Development | 46.23M | 52.68M | 48.79M | 40.16M | 49.54M | 44.79M | 55.01M | 45.39M | 49.85M | 36.83M | 30.8M | 28.77M | 20.58M | 17.79M | 14.69M | 14.88M | 15.79M | 12.59M | 13.78M | 13.18M | 14.5M | 16.6M |
Other Expenses | 93K | 2.16M | -4.99M | 14.79M | -6.51M | 3.08M | 12.59M | 18M | 3.75M | 177K | 44.81M | 1.43M | 7.64M | 1.41M | 5.81M | 1.57M | 66K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 254.46M | 239.84M | 213.1M | 205.19M | 173.31M | 168.66M | 180.87M | 158.95M | 157.16M | 135.98M | 162.43M | 113.38M | 107.16M | 93.39M | 82M | 57.33M | 47.02M | 38.29M | 32.61M | 33.41M | 30.85M | 27.84M |
Interest Expense | 1.54M | 1.19M | 1.17M | 1.12M | 1.83M | 2.43M | 2.21M | 1.98M | 1.3M | 1.08M | 702K | 757K | 2.73M | 2.26M | 1.32M | 2.41M | 2.26M | 1.34M | 1.37M | 1.48M | 1.44M | 1.42M |
Selling & Marketing Expenses | n/a | n/a | n/a | 41.4M | 36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.7M | n/a | n/a | -443 | -140 | 269 | n/a | n/a | n/a | 286.92K |
Cost & Expenses | 268.02M | 254.56M | 225.43M | 217.1M | 186.76M | 178.45M | 191.38M | 167.39M | 165.21M | 142.27M | 169.8M | 119.91M | 111.76M | 100.95M | 84.29M | 59.26M | 48M | 38.29M | 32.61M | 33.41M | 30.85M | 27.84M |
Income Tax Expense | 128K | n/a | 430K | n/a | -960K | n/a | 85K | n/a | n/a | n/a | -325K | -678K | -617K | 2.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 51.5M | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
Shares Outstanding (Diluted) | 51.5M | 51.2M | 50.63M | 50.02M | 49.44M | 48.87M | 48.54M | 48.14M | 47.57M | 47.39M | 47.33M | 47.12M | 43.67M | 43.52M | 43.45M | 41.7M | 39.08M | 38.32M | 37.76M | 37.68M | 37.6M | 37.43M |
EPS (Basic) | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 | -1.07 | -1.06 | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EPS (Diluted) | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 | -1.07 | -1.06 | -1.03 | -0.90 | -0.93 | -0.86 | -0.78 |
EBITDA | -49.65M | -61.08M | -24.68M | -44.38M | -42.57M | -54.85M | -70.54M | -60.56M | -76.05M | -65.44M | -96.53M | -60.38M | -62.91M | -4.71M | -57.9M | -40.73M | -38.79M | -37.98M | -32.3M | -33.11M | -30.57M | -27.57M |
EBIT | -49.65M | -63.36M | -26.96M | -46.11M | -44.82M | -56.98M | -72.62M | -62.62M | -78.05M | -67.28M | -98.27M | -62.12M | -65.06M | -6.37M | -59.92M | -42.41M | -39.18M | -38.29M | -32.61M | -33.41M | -30.85M | -27.84M |
Depreciation & Amortization | n/a | 2.27M | 2.27M | 1.73M | 2.25M | 2.13M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 2.15M | 1.66M | 2.02M | 1.68M | 393.35K | 312K | 307.41K | 299.74K | 277.42K | 271.09K |
Add to Watchlist
Select watchlists to add or remove AXSM